A

Agilent Technologies
D

A

Arincen80/100B

Agilent Technologies revenue 1998–2026

Agilent Technologies's revenue in Q3 FY2026, the three months to 31 July 2026, was 1.88B USD, up 8.1% on the same quarter a year before. Agilent Technologies's revenue over the last twelve months was 7.37B USD, up 8.6% on the twelve months before. In fiscal year 2025 it was 6.95B USD, up 6.7% on the year before.

Last updated 7 Nov 2026 · Next report 23 Nov 2026

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM31 Jul 20267.37B+8.60%3.96B1.44B
FY202531 Oct 20256.95B+6.73%3.64B1.30B
FY202431 Oct 20246.51B-4.73%3.54B1.29B
FY202331 Oct 20236.83B-0.22%3.47B1.24B
FY202231 Oct 20226.85B+8.37%3.72B1.25B
FY202131 Oct 20216.32B+18.36%3.41B1.21B
FY202031 Oct 20205.34B+3.41%2.84B719.00M
FY201931 Oct 20195.16B+5.07%2.81B1.07B
FY201831 Oct 20184.91B+9.88%2.69B316.00M
FY201731 Oct 20174.47B+6.43%2.41B684.00M
FY201631 Oct 20164.20B+4.06%2.20B460.00M
FY201531 Oct 20154.04B-0.25%2.04B401.00M
FY201431 Oct 20144.05B+3.95%1.98B549.00M
FY201331 Oct 20133.89B-43.22%1.91B724.00M
FY201231 Oct 20126.86B+3.67%3.60B1.15B
FY201131 Oct 20116.62B+21.51%3.53B1.01B
FY201031 Oct 20105.44B+21.49%2.93B684.00M
FY200931 Oct 20094.48B-22.39%2.29B-31.00M
FY200831 Oct 20085.77B+6.53%3.20B693.00M
FY200731 Oct 20075.42B+8.99%2.97B638.00M
FY200631 Oct 20064.97B-3.23%2.66B3.31B
FY200531 Oct 20055.14B-28.44%2.52B141.00M
FY200431 Oct 20047.18B+60.72%3.12B369.00M
FY200331 Oct 20034.47B-25.66%1.94B-2.06B
FY200231 Oct 20026.01B-28.42%2.32B-1.03B
FY200131 Oct 20018.40B-10.31%3.23B168.00M
FY200031 Oct 20009.36B+37.06%4.78B757.00M
FY199931 Oct 19996.83B-14.11%3.20B512.00M
FY199831 Oct 19987.95B—3.92B257.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Agilent Technologies revenue growth by segment

Q3 FY2026 against Q3 FY2025

Agilent CrossLab786.00M
+5.6%
Life Sciences and Applied Markets746.00M
+11.3%
Applied Markets346.00M
+6.8%

Agilent Technologies revenue by segment over time

Agilent CrossLab Life Sciences and Applied Markets Applied Markets Diagnostics and Genomics
Fiscal yearAgilent CrossLabLife Sciences and Applied MarketsApplied MarketsDiagnostics and Genomics
FY20252.91B +76.9%2.73B -15.2%1.31B —
FY20241.64B +4.8%3.22B -16.6%— 1.65B +17.2%
FY20231.57B +8.0%3.86B -3.8%— 1.41B +1.4%
FY20221.45B -34.0%4.01B +41.9%— 1.39B +7.2%
FY20212.20B +15.8%2.82B +18.0%— 1.30B +23.8%
FY20201.90B +3.3%2.39B +3.9%— 1.05B +2.5%
FY20191.84B +8.2%2.30B +1.4%— 1.02B +8.3%
FY20181.70B +11.1%2.27B +4.7%— 943.00M +22.2%
FY20171.53B +7.8%2.17B +4.6%— 772.00M +8.9%
FY20161.42B 2.07B — 709.00M +7.1%

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Agilent Technologies's revenue

Source: Financial Modeling PrepVerified against SEC filings